Results

Total Results: 1,991 records

Showing results for "participants".

  1. effectivehealthcare.ahrq.gov/products/meditation/research-protocol
    October 17, 2012 - , and receipt of intervention by measuring 1) duration of structured training in meditation for the participants … Did the strategy for recruiting participants into the study differ across study groups? … Detection Bias: Were those who collected data on the participants blind to the allocation? … /exposures assessed using valid and reliable measures and implemented consistently across all study participants … There are concerns that participants in meditation studies are highly selected, such as trained meditators
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-executive-170505.pdf
    May 01, 2017 - from 2010—present and not addressed in prior reviews Studies must have relevant population and ≥20 participants … with ASD (non-RCTs) or at least 10 total participants (RCTs) Studies must address one or more of the … Most studies were small (median 40 total participants/ study) and addressed variable agents. … Applicability Study participants were generally recruited from specialty clinical service programs … While duration was typically short, retaining participants in studies, especially in placebo arms,
  3. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/version-2-risk-of-reinfection-from-SARSCoV2.pdf
    July 01, 2022 - selection bias could arise from the data sources used to identify eligible individuals or the ways participants … Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure … (participants without antecedent of SARS-CoV-2 infection) Group 2: Previously SARS CoV-2 infected … participants (participants with antecedent of SARS-CoV-2 infection [more than 6 months]) IgG humoral … : Parents or guardians of participants in all cohorts will also be enrolled for limited participation
  4. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/version-2-risk-of-reinfection-from-SARSCoV2.pdf
    July 01, 2022 - selection bias could arise from the data sources used to identify eligible individuals or the ways participants … Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure … (participants without antecedent of SARS-CoV-2 infection) Group 2: Previously SARS CoV-2 infected … participants (participants with antecedent of SARS-CoV-2 infection [more than 6 months]) IgG humoral … : Parents or guardians of participants in all cohorts will also be enrolled for limited participation
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/smoking-pregnancy-infants_disposition-comments.pdf
    February 25, 2014 - Therefore, four studies of pregnant current smokers with fewer than 50 participants per group contributed … Reviewer 12 Methods The authors chose a sample size of 20 participants for each study arm as inclusion … We contacted the author for clarification of the number of participants but did not receive a response … We contacted the author for clarification of the number of participants but did not receive a response … The reviewers agreed that participants in the control group did not receive a placebo patch and thus
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
    December 31, 2022 - In all three studies, a high proportion of participants had detectable IgG over the long- term.11-13 … In the largest study, conducted among 367 adults in Finland, 97 percent of participants had detectable … about reinfection, studies could not rule out the possibility that participants had an asymptomatic … participants at regular intervals (e.g., monthly), individuals who had an initial IgG response but … Third, most studies were small (fewer than 200 participants), leading to lack of precision in estimates
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
    November 01, 2023 - situation where they differed by medication or placebo arm or where there were higher numbers of affected participants … Compared with placebo, study participants treated with acamprosate were more likely to experience anxiety … One trial (N=100) that recruited participants primarily by advertisement in two family medicine settings
  8. effectivehealthcare.ahrq.gov/products/carioverter-difibrillators/abstract
    April 14, 2010 - Participants, setting, and expected sample size: The study utilizes the following: a) >400,000 patients
  9. Slide 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/cf__deliberativemethodswebinar_deliberativemethodsexperiment.pdf
    June 01, 2012 - ’ Panel  4 locations: DC, Chicago, Sacramento, Raleigh-Durham  76 deliberative groups; 1,296 participants
  10. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-protocol.pdf
    April 01, 2022 - Exclude: Institutionalized settings (e.g., prisons) Design ● Randomized controlled trials (N ≥10 participants … per group) ● Nonrandomized comparative studies, longitudinal (prospective or retrospective) (N ≥30 participants … per group) ● Case-control studies (N ≥30 participants per group) ● Exclude: Single-group (noncomparative … per group) ● Case-control studies (N ≥30 participants per group) ● Exclude: Single-group (noncomparative … Strategies to Promote Postpartum Visit Attendance Among Medicaid Participants.
  11. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
    April 25, 2022 - Exclude: Institutionalized settings (e.g., prisons) Design ● Randomized controlled trials (N ≥10 participants … per group) ● Nonrandomized comparative studies, longitudinal (prospective or retrospective) (N ≥30 participants … per group) ● Case-control studies (N ≥30 participants per group) ● Exclude: Single-group (noncomparative … per group) ● Case-control studies (N ≥30 participants per group) ● Exclude: Single-group (noncomparative … Strategies to Promote Postpartum Visit Attendance Among Medicaid Participants.
  12. Table 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-indicators-symposium_research.pdf
    April 01, 2010 - Methods Symposium participants were divided into multidisciplinary groups to address the identified … and presentation after the symposium and solicited further comments from the group moderators and participants … For areas with more indicator development, participants felt that there had been sufficient development … The issue of ideal sources of information was also difficult to resolve, as participants identified … Participants did agree on a number of challenges that remain across domains.
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-prevention-covid-healthcare-community-amended-protocol.pdf
    July 02, 2020 - research purposes, but should not be considered current. 2 Inclusion and Exclusion Criteria Participants … Review Protocol Condition or Domain Being Studied Key Questions Inclusion and Exclusion Criteria Participants
  14. effectivehealthcare.ahrq.gov/products/cancer-anemia-update/research-protocol
    June 16, 2010 - Trials with 50 or fewer randomized participants per study arm for studies of adults; 10 or fewer participants … Types of participants Only participants diagnosed with malignant disease, using clinical or histological … Were the participants anemic or at risk for anemia from chemotherapy and/or radiotherapy? … Were the participants anemic or at risk for anemia from chemotherapy and/or radiotherapy? … Were study participants blinded (masked) to the treatment they received?
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
    June 16, 2010 - Trials with 50 or fewer randomized participants per study arm for studies of adults; 10 or fewer participants … Types of participants Only participants diagnosed with malignant disease, using clinical or histological … Were the participants anemic or at risk for anemia from chemotherapy and/or radiotherapy? 4. … Were the participants anemic or at risk for anemia from chemotherapy and/or radiotherapy? 6. … Were study participants blinded (masked) to the treatment they received? 4.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_executive.pdf
    May 01, 2015 - with ankyloglossia or ankyloglossia with concomitant tight labial frenulum (lip-tie); studies with participants … likely factors that could affect applicability are the severity/degree of ankyloglossia, age range of participants … ability to clean teeth with tongue, lick outside of lips, and eat ice cream compared with untreated participants … using the tongue to clean the teeth and for licking in the treatment group compared with untreated participants … addressing surgical approaches for ankyloglossia Outcome; Number of Studies and Quality (Total Participants
  17. effectivehealthcare.ahrq.gov/products/cognitive-measures-harmonization/research
    March 21, 2013 - Cross-sectional data from three studies including 9,269 participants were included in the applied analyses
  18. Goal Setting (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/delilberative-methods-design-gupta.pdf
    January 11, 2017 - Goals Before Forums  Research & analysis of issues  Reach beyond usual suspects  Build trust of participants
  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
    September 01, 2011 - All studies were from the United States, and participants were recruited either from single-center study … were recruited, the question of overlap in participants across these studies was an important concern … Therefore, where appropriate, we report this risk of double- counting of participants. … In several studies, participants received specialized outpatient services from Matria Healthcare. … In addition, several of the cohort studies investigated participants from a single proprietary database
  20. effectivehealthcare.ahrq.gov/sites/default/files/module-ii-stakeholders-and-stakeholder-engagement.pdf
    June 01, 2011 - Slide 5 Module II Learning Objectives After completing Module II, participants will be able to: … Speaker notes: After completing Module II, participantsParticipants vote on top priorities. … Participants vote on top priorities. … Stakeholders may be engaged throughout the research process in different ways; as key informants, as participants

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: